Some years ago, Bluetongue virus (BTV) caused millions in economic damages as well as illness, lameness, deformed offspring and death amongst sheep and cattle. It is only a matter of time before the next outbreak.
Researchers at Wageningen UR developed an innovative prototype vaccine which is expected to be more effective than existing ones. This means that the disease can be more easily contained. Furthermore, the new vaccine can be easily adapted to combat new viral variants. In collaboration with a manufacturer, the vaccine can soon be made available to livestock farmers. This is also how Wageningen UR works on the quality of life.